• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颅内动脉粥样硬化性狭窄的血管成形术、支架置入术及其他潜在治疗方法:过去、现在与未来

Angioplasty, Stenting and Other Potential Treatments of Atherosclerotic Stenosis of the Intracranial Arteries: Past, Present and Future.

作者信息

Wabnitz Ashley, Chimowitz Marc

机构信息

Department of Neurology, Medical University of South Carolina, Charleston, SC, USA.

出版信息

J Stroke. 2017 Sep;19(3):271-276. doi: 10.5853/jos.2017.01837. Epub 2017 Sep 29.

DOI:10.5853/jos.2017.01837
PMID:29037013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5647644/
Abstract

Although there is an intuitive appeal to treat symptomatic stenotic intracranial arteries with endovascular therapies such as angioplasty and stenting, current data from randomized trials show intensive medical therapy is far superior for preventing stroke. This is in large part due to the high risk of peri-procedural stroke from angioplasty and stenting. If angioplasty and stenting is to emerge as a proven treatment for intracranial stenosis, endovascular techniques will need to become much safer, identification of patients with intracranial stenosis who are at particularly high risk of stroke despite intensive medical therapy will need to be targeted, and well-designed randomized trials will be necessary to show endovascular therapy is superior to medical therapy in these high-risk patients.

摘要

尽管采用血管成形术和支架置入术等血管内治疗方法来治疗有症状的颅内动脉狭窄在直观上具有吸引力,但随机试验的当前数据表明,强化药物治疗在预防中风方面要优越得多。这在很大程度上是由于血管成形术和支架置入术存在围手术期中风的高风险。如果血管成形术和支架置入术要成为颅内狭窄的一种经证实的治疗方法,血管内技术将需要变得更加安全,需要针对那些尽管接受了强化药物治疗但仍有特别高的中风风险的颅内狭窄患者进行识别,并且需要精心设计的随机试验来证明血管内治疗在这些高风险患者中优于药物治疗。

相似文献

1
Angioplasty, Stenting and Other Potential Treatments of Atherosclerotic Stenosis of the Intracranial Arteries: Past, Present and Future.颅内动脉粥样硬化性狭窄的血管成形术、支架置入术及其他潜在治疗方法:过去、现在与未来
J Stroke. 2017 Sep;19(3):271-276. doi: 10.5853/jos.2017.01837. Epub 2017 Sep 29.
2
Stenting and angioplasty of small cerebral arteries in symptomatic intracranial atherosclerotic disease.有症状颅内动脉粥样硬化性疾病中小脑动脉的支架置入术和血管成形术。
Interv Neurol. 2014 May 1;2(3):123-131. doi: 10.1159/000357453.
3
China Angioplasty and Stenting for Symptomatic Intracranial Severe Stenosis (CASSISS): A new, prospective, multicenter, randomized controlled trial in China.中国症状性颅内重度狭窄血管成形术和支架置入术(CASSISS):一项在中国开展的新的前瞻性多中心随机对照试验。
Interv Neuroradiol. 2015 Apr;21(2):196-204. doi: 10.1177/1591019915581778. Epub 2015 May 1.
4
Revisiting angioplasty without stenting for symptomatic intracranial atherosclerotic stenosis after the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) study.SAMMPRIS 研究后,对于症状性颅内动脉粥样硬化狭窄患者,血管成形术不伴支架置入治疗能否替代支架置入和强化药物治疗预防颅内狭窄患者卒中复发。
Neurosurgery. 2012 Dec;71(6):1103-10. doi: 10.1227/NEU.0b013e318271bcb8.
5
Submaximal angioplasty for symptomatic intracranial atherosclerosis: a prospective Phase I study.症状性颅内动脉粥样硬化的次最大血管成形术:一项前瞻性 I 期研究。
J Neurosurg. 2016 Oct;125(4):964-971. doi: 10.3171/2015.8.JNS15791. Epub 2016 Jan 8.
6
Intracranial angioplasty and stent placement after stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) trial: present state and future considerations.支架置入后颅内血管成形术和支架置入与强化药物治疗预防颅内狭窄患者卒中复发(SAMMPRIS)试验:现状与未来思考。
J Neuroimaging. 2012 Jan;22(1):1-13. doi: 10.1111/j.1552-6569.2011.00685.x.
7
Angioplasty and stenting for intracranial atherosclerotic stenosis: position statement of the Hong Kong Society of Interventional and Therapeutic Neuroradiology.血管成形术和支架置入治疗颅内动脉粥样硬化性狭窄:香港介入治疗神经放射学学会立场声明。
Hong Kong Med J. 2013 Feb;19(1):69-73.
8
Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trial.动脉粥样硬化性颅内狭窄的血管成形术和支架置入术:一项随机临床试验的理论依据
Neuroimaging Clin N Am. 2007 Aug;17(3):355-63, viii-ix. doi: 10.1016/j.nic.2007.05.001.
9
Undersized angioplasty and stenting of symptomatic intracranial tight stenosis with Enterprise: Evaluation of clinical and vascular outcome.使用Enterprise进行症状性颅内重度狭窄的小型血管成形术和支架置入术:临床和血管结局评估
Interv Neuroradiol. 2016 Apr;22(2):187-95. doi: 10.1177/1591019915609165. Epub 2015 Nov 4.
10
Stenting in Intracranial Stenosis: Current Controversies and Future Directions.颅内狭窄的支架置入术:当前争议与未来方向
Curr Atheroscler Rep. 2015 Aug;17(8):48. doi: 10.1007/s11883-015-0527-4.

引用本文的文献

1
Comparing Stenting with Medical Therapy Versus Medical Therapy Alone in Patients with Intracranial Atherosclerotic Stenosis: A Current Systematic Review and Meta-Analysis.颅内动脉粥样硬化性狭窄患者支架置入术与单纯药物治疗的比较:当前的系统评价和荟萃分析
Clin Pract. 2025 Jun 19;15(6):113. doi: 10.3390/clinpract15060113.
2
Effect of Drug-Coated Balloon Versus Stent Angioplasty in Patients With Symptomatic Intracranial Atherosclerotic Stenosis.药物涂层球囊与支架血管成形术治疗症状性颅内动脉粥样硬化狭窄患者的疗效比较
Oper Neurosurg (Hagerstown). 2024 Dec 1;27(6):730-738. doi: 10.1227/ons.0000000000001200. Epub 2024 May 23.
3
A comprehensive review of stroke-related signaling pathways and treatment in western medicine and traditional Chinese medicine.中西医中与中风相关的信号通路及治疗的综合综述。
Front Neurosci. 2023 Jun 7;17:1200061. doi: 10.3389/fnins.2023.1200061. eCollection 2023.
4
A non-linear relationship between lesion length and risk of recurrent cerebral ischemia after stenting for symptomatic intracranial stenosis with hemodynamic impairment.对于有血流动力学损害的症状性颅内狭窄患者,支架置入术后病变长度与复发性脑缺血风险之间存在非线性关系。
Front Neurol. 2023 Apr 18;14:1122708. doi: 10.3389/fneur.2023.1122708. eCollection 2023.
5
Intracranial angioplasty with a self-expandable stent for intracranial atherosclerotic stenosis: Systematic review and meta-analysis.使用自膨式支架治疗颅内动脉粥样硬化性狭窄的颅内血管成形术:系统评价和荟萃分析。
Front Neurol. 2023 Jan 9;13:1074228. doi: 10.3389/fneur.2022.1074228. eCollection 2022.
6
Plaque characteristics after endovascular treatment in patients with intracranial atherosclerotic disease.颅内动脉粥样硬化疾病患者血管内治疗后的斑块特征
Chin Neurosurg J. 2022 Dec 2;8(1):37. doi: 10.1186/s41016-022-00302-3.
7
Short-term outcome of stenting with Enterprise stents for symptomatic intracranial atherosclerotic disease at a single center.单中心Enterprise 支架治疗症状性颅内动脉粥样硬化疾病的短期结果。
Interv Neuroradiol. 2023 Dec;29(6):731-737. doi: 10.1177/15910199221133166. Epub 2022 Oct 19.
8
Factors Influencing the Outcome of Symptomatic Intracranial Artery Stenosis With Hemodynamic Impairment After Short and Long-Term Stent Placement.短期和长期支架置入术后影响有血流动力学损害的症状性颅内动脉狭窄结局的因素。
Front Neurol. 2022 May 17;13:682694. doi: 10.3389/fneur.2022.682694. eCollection 2022.
9
Intracranial Angioplasty with Enterprise Stent for Intracranial Atherosclerotic Stenosis: A Single-Center Experience and a Systematic Review.颅内动脉血管成形术联合 Enterprise 支架治疗颅内动脉粥样硬化性狭窄:单中心经验和系统评价。
Biomed Res Int. 2021 Apr 17;2021:6645500. doi: 10.1155/2021/6645500. eCollection 2021.
10
Intracranial Stenting; the Current Landscape.颅内支架置入术;当前形势
Neurointervention. 2021 Mar;16(1):2-5. doi: 10.5469/neuroint.2021.00087. Epub 2021 Feb 24.

本文引用的文献

1
Angioplasty and stenting for patients with symptomatic intracranial atherosclerosis: study protocol of a randomised controlled trial.症状性颅内动脉粥样硬化患者的血管成形术和支架置入术:一项随机对照试验的研究方案
BMJ Open. 2016 Nov 15;6(11):e012175. doi: 10.1136/bmjopen-2016-012175.
2
Factors Associated With Recurrent Ischemic Stroke in the Medical Group of the SAMMPRIS Trial.SAMMPRIS试验医疗组中复发性缺血性卒中的相关因素。
JAMA Neurol. 2016 Mar;73(3):308-15. doi: 10.1001/jamaneurol.2015.4315.
3
Effect of Hemodynamics on Stroke Risk in Symptomatic Atherosclerotic Vertebrobasilar Occlusive Disease.血流动力学对有症状的动脉粥样硬化性椎基底动脉闭塞性疾病中风风险的影响。
JAMA Neurol. 2016 Feb;73(2):178-85. doi: 10.1001/jamaneurol.2015.3772.
4
Does the Stenting Versus Aggressive Medical Therapy Trial Support Stenting for Subgroups With Intracranial Stenosis?支架置入术与强化药物治疗试验是否支持对颅内狭窄亚组进行支架置入?
Stroke. 2015 Nov;46(11):3282-4. doi: 10.1161/STROKEAHA.115.009846. Epub 2015 Sep 17.
5
Thirty-Day Outcome of a Multicenter Registry Study of Stenting for Symptomatic Intracranial Artery Stenosis in China.中国症状性颅内动脉狭窄支架置入多中心注册研究的30天结果
Stroke. 2015 Oct;46(10):2822-9. doi: 10.1161/STROKEAHA.115.010549. Epub 2015 Aug 18.
6
Ischemic Conditioning Is Safe and Effective for Octo- and Nonagenarians in Stroke Prevention and Treatment.缺血预处理对八旬和九旬老人预防及治疗中风安全有效。
Neurotherapeutics. 2015 Jul;12(3):667-77. doi: 10.1007/s13311-015-0358-6.
7
Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial.球囊扩张颅内支架与药物治疗对症状性颅内狭窄患者卒中风险的影响:VISSIT 随机临床试验。
JAMA. 2015;313(12):1240-8. doi: 10.1001/jama.2015.1693.
8
Mechanisms of human erythrocytic bioactivation of nitrite.亚硝酸盐的人体红细胞生物活化机制。
J Biol Chem. 2015 Jan 9;290(2):1281-94. doi: 10.1074/jbc.M114.609222. Epub 2014 Dec 3.
9
Infarct patterns, collaterals and likely causative mechanisms of stroke in symptomatic intracranial atherosclerosis.症状性颅内动脉粥样硬化性卒中的梗死模式、侧支循环及可能的致病机制
Cerebrovasc Dis. 2014;37(6):417-22. doi: 10.1159/000362922. Epub 2014 Jul 4.
10
Circulating nitrite contributes to cardioprotection by remote ischemic preconditioning.循环亚硝酸盐通过远程缺血预处理发挥心脏保护作用。
Circ Res. 2014 May 9;114(10):1601-10. doi: 10.1161/CIRCRESAHA.114.303822. Epub 2014 Mar 18.